Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-1 inhibitor with chemotherapy in resectable gastric or gastroesophageal junction adenocarcinoma
NCT07149181Phase 4Not yet recruiting
- Sponsor
- Liaoning Medical Center
- Start
- Aug 2025
- Primary completion
- Aug 2025
01
Overview
Phase 4, open-label trial in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma, sponsored by Liaoning Medical Center. Planned start Aug 2025; status: not yet recruiting.
02
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT07149181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07149181.